loadpatents
Patent applications and USPTO patent grants for Goodenow; Robert.The latest application filed is for "methods and compositions for genetic modulation of tumor microenvironments".
Patent | Date |
---|---|
Sulcardine salts Grant 11,426,382 - Romano , et al. August 30, 2 | 2022-08-30 |
Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer Grant 11,324,822 - Goodenow , et al. May 10, 2 | 2022-05-10 |
Methods And Compositions For Genetic Modulation Of Tumor Microenvironments App 20220110924 - BISSONNETTE; Reid P. ;   et al. | 2022-04-14 |
Sulcardine Administration For Treatment Of Acute Atrial Fibrillation App 20210386708 - ELLIOTT; Gary ;   et al. | 2021-12-16 |
Sulcardine salts Grant 11,020,374 - Romano , et al. June 1, 2 | 2021-06-01 |
Sulcardine Salts App 20210038568 - ROMANO; Suzanne J. ;   et al. | 2021-02-11 |
Sulcardine Salts App 20200316024 - Romano; Suzanne J. ;   et al. | 2020-10-08 |
Methods For The Treatment Of Breast Cancer App 20190343844 - GOODENOW; Robert ;   et al. | 2019-11-14 |
Methods for the treatment of breast cancer Grant 10,226,472 - Goodenow , et al. | 2019-03-12 |
Combination Therapies Of Hdac Inhibitors And Tubulin Inhibitors App 20190046513 - Bissonnette; Reid P. ;   et al. | 2019-02-14 |
Combination Of Hdac Inhibitor And Anti-pd-l1 Antibody For Treatment Of Cancer App 20180353602 - GOODENOW; Robert ;   et al. | 2018-12-13 |
Combination Of Hdac Inhibitor And Anti-pd-1 Antibody For Treatment Of Cancer App 20180078639 - GOODENOW; Robert ;   et al. | 2018-03-22 |
Methods For The Treatment Of Breast Cancer App 20140378420 - Goodenow; Robert ;   et al. | 2014-12-25 |
Methods For The Treatment Of Lung Cancer App 20130150386 - Goodenow; Robert ;   et al. | 2013-06-13 |
Administration of an Inhibitor of HDAC App 20100305167 - Burk; Konrad ;   et al. | 2010-12-02 |
Novel Compounds and Methods of Using Them App 20100298270 - Keana; John F.W. ;   et al. | 2010-11-25 |
Novel Compounds and Methods of Using Them App 20100267779 - Keana; John F.W. ;   et al. | 2010-10-21 |
Administration of an Inhibitor of HDAC and an mTOR Inhibitor App 20090149511 - Burk; Konrad ;   et al. | 2009-06-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.